Healthcare
Healthcare
Prostate Cancer Cases to Double by 2040, Study Finds
A recent study published in The Lancet medical journal has projected a substantial increase in global prostate cancer cases and deaths by the...
ALS Drug Relyvrio Withdrawn Due to Ineffectiveness
Amylyx Pharmaceuticals has decided to withdraw its ALS drug Relyvrio from the market following disappointing results from a phase III trial. The drug,...
Global Life Expectancy Rises 6.2 Years, Pandemic Stalls Progress
A recent Lancet study reveals that global life expectancy increased by 6.2 years between 1990 and 2021. This rise was fueled by reductions...
Genetic Variants Increase Obesity Risk Six-Fold
New Genetic Variants Discovered, Potentially Increasing Obesity Risk Six-Fold A groundbreaking study published in Nature Genetics has unveiled two genetic variants that could...
Oregon Reverses Drug Decriminalization, Adds Jail Terms
Oregon is reversing its drug decriminalization law, opting instead for new penalties for drug possession. Governor Tina Kotek signed a bill adding misdemeanor...
Pentagon Confirms ‘Havana Syndrome’ at 2023 NATO Summit
A senior official from the Department of Defense who participated in the NATO summit in Vilnius, Lithuania, in 2023, experienced symptoms consistent with...
Second U.S. Bird Flu Case Linked to Infected Cattle in Texas
Texas health officials recently confirmed the second case of avian influenza (bird flu) in a human in the United States. The patient contracted...
CDC Warns of Norovirus Surge, Especially in Northeast U.S
The Centers for Disease Control and Prevention (CDC) has issued a concerning report on the surge of norovirus cases sweeping across the United...
Study Links Covid Vaccines to Rare Heart, Brain Risks
A recent peer-reviewed study has found a potential link between Covid-19 vaccines and rare occurrences of heart and brain disorders. The study, conducted...
FDA OKs Xolair as First Drug for Multiple Food Allergies
The FDA has greenlit Xolair, a medication developed by Novartis Pharmaceuticals and Genentech, as the first drug for reducing allergic reactions to one...
